ADVFN Logo
Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
Akcea Therapeutics Inc

Akcea Therapeutics Inc (AKCA)

18.17
0.00
(0.00%)
Closed September 20 4:00PM
18.17
0.00
( 0.00% )
Pre Market: 8:00PM

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
18.17
Bid
18.08
Ask
19.00
Volume
-
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Previous Close
18.17
Open
-
Last Trade
Last Trade Time
-
Average Volume (3m)
-
Financial Volume
-
VWAP
-

AKCA Latest News

Ionis and Akcea win prestigious Prix Galien Award for TEGSEDI® (inotersen) as Best Biotechnology Product

Ionis and Akcea win prestigious Prix Galien Award for TEGSEDI® (inotersen) as Best Biotechnology Product PR Newswire BOSTON and CARLSBAD, Calif., Oct. 30, 2020 BOSTON and CARLSBAD, Calif., Oct...

Ionis Pharmaceuticals completes acquisition of Akcea Therapeutics

Ionis Pharmaceuticals completes acquisition of Akcea Therapeutics Transaction creates a stronger, more efficient company PR Newswire CARLSBAD, Calif., Oct. 12, 2020 CARLSBAD, Calif., Oct. 12...

WAYLIVRA▼® (volanesorsen), the First & Only Therapy for FCS, an Ultra-Rare & Life-Threatening Condition, to Be Available o...

National Institute for Health and Care Excellence (NICE) issues a positive recommendation for volanesorsen to treat adults with Familial Chylomicronaemia Syndrome (FCS) Akcea Therapeutics UK...

Ionis Pharmaceuticals to acquire remaining stake in Akcea Therapeutics

Ionis Pharmaceuticals to acquire remaining stake in Akcea Therapeutics - Ionis to acquire remaining 24% of common stock of Akcea it does not already own for $18.15 per share in cash - Transaction...

Positive Phase 2 Clinical Data of Vupanorsen (AKCEA-ANGPTL3-L(Rx)) Presented at ESC Congress 2020

Positive Phase 2 Clinical Data of Vupanorsen (AKCEA-ANGPTL3-L(Rx)) Presented at ESC Congress 2020 Results from Phase 2 study demonstrate patients receiving vupanorsen experienced significant...

Positive Phase 2 Clinical Data of AKCEA-APOCIII-L(Rx) Presented at ESC Congress 2020

Positive Phase 2 Clinical Data of AKCEA-APOCIII-L(Rx) Presented at ESC Congress 2020 Results in late-breaking presentation show patients with hypertriglyceridemia experienced dose-dependent...

Akcea and Ionis to Present Phase 2 Clinical Data of Vupanorsen (AKCEA-ANGPTL3-L (Rx) ) at ESC Congress 2020

Akcea and Ionis to Present Phase 2 Clinical Data of Vupanorsen (AKCEA-ANGPTL3-L (Rx) ) at ESC Congress 2020 Late-breaking presentation to focus on efficacy and safety data of vupanorsen in...

Akcea and Ionis to Present Phase 2 Results of AKCEA-APOCIII-L(Rx) in Late-Breaking Presentation at ESC Congress 2020

Akcea and Ionis to Present Phase 2 Results of AKCEA-APOCIII-L(Rx) in Late-Breaking Presentation at ESC Congress 2020 Data presentation will highlight efficacy, safety and tolerability of...

Akcea Announces New Pricing and Reimbursement of WAYLIVRA® (volanesorsen) in Germany

Akcea Announces New Pricing and Reimbursement of WAYLIVRA® (volanesorsen) in Germany WAYLIVRA is the only treatment option for patients with familial chylomicronemia syndrome, or FCS, in...

Akcea Reports Financial Results and Highlights for Second Quarter 2020

Akcea Reports Financial Results and Highlights for Second Quarter 2020 Global Net Product Revenues of $16 Million, an Increase of 66% Year-Over-Year Achieved Pricing and Reimbursement Across Key...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
NUKKNukkleus Inc
$ 0.3858
(81.55%)
10.58M
SOXMTradr 2X Long SOXX Monthly ETF
$ 36.96
(58.98%)
19
LGCBLinkage Global Inc
$ 0.6491
(55.18%)
5.69M
LGHLWLion Group Holding Ltd
$ 0.008
(33.33%)
11
SPPLSIMPPLE Ltd
$ 0.48
(31.51%)
1
PRFXPainReform Ltd
$ 0.572
(-25.82%)
10.58k
ZJYLJin Medical International Ltd
$ 3.20
(-21.57%)
17.94k
CJETChijet Motor Company Inc
$ 2.28
(-18.57%)
694
HRYUHanryu Holdings Inc
$ 0.19
(-17.75%)
2.44k
MYNZMainz BioMed NV
$ 0.20
(-17.70%)
322.6k
NUKKNukkleus Inc
$ 0.3858
(81.55%)
10.58M
LGCBLinkage Global Inc
$ 0.6491
(55.18%)
5.69M
MAXNMaxeon Solar Technologies Ltd
$ 0.0781
(-14.64%)
2.34M
GSIWGarden Stage Ltd
$ 1.69
(26.12%)
2.14M
TGLTreasure Global Inc
$ 0.875
(28.62%)
1.5M

AKCA Discussion

View Posts
Sidney Sidney 6 years ago
Any thoughts on why so low today?
👍️0
Thoro Thoro 7 years ago
So Volatile. Any thoughts on why the big plunge today?
👍️0
Rodney213 Rodney213 7 years ago
Like how clean the board is .Some heavy price target coverage today
👍️0
dinosaurbob dinosaurbob 7 years ago
Dropped heavy yesterday but bounced back some today. I am still up 17%, so I am not complaining.
👍️0
Thoro Thoro 7 years ago
This is a volatile stock. Its finding its legs.
👍️0
dinosaurbob dinosaurbob 7 years ago
Closed at $15.43 today up 47 cents.
👍️0
dinosaurbob dinosaurbob 7 years ago
Back up $1.02 today. This stock is like riding a roller coaster. Up one day and down the next. And big drops and rises too.
👍️0
dinosaurbob dinosaurbob 7 years ago
WTH happened today? Down $1.52!
👍️0
dinosaurbob dinosaurbob 7 years ago
Closed up 40 cents at $14.88
👍️0
dinosaurbob dinosaurbob 7 years ago
It was up big earlier but steadily dropping now. Still up 14 cents at 2:45 EST
👍️0
Thoro Thoro 7 years ago
AKCA, Akcea and Ionis Announce Submission of Marketing Authorization Application for Volanesorsen to the European Medicines Agency

https://ih.advfn.com/p.php?pid=nmona&article=75321782
👍️0
dinosaurbob dinosaurbob 7 years ago
Closed up at $14.48 (5.16%). Nice!
👍️0
Thoro Thoro 7 years ago
I know it dropped, but I like when it tests higher.
👍️0
dinosaurbob dinosaurbob 7 years ago
Yes, but it dropped to $13.77. I still believe in it though.
👍️0
Thoro Thoro 7 years ago
AKCA $16.30 looked great today!
👍️0
dinosaurbob dinosaurbob 7 years ago
I bought in at 9.88 and then doubled my portfolio Friday at $13.00. I see this over $20.00 by October!
👍️0
Thoro Thoro 7 years ago
AKCA

IPO doing great first 5 days of trading.
👍️0
Thoro Thoro 7 years ago
AKCA

#MARKET NEWS
JULY 14, 2017 / 12:12 PM / 3 DAYS AGO
BRIEF-Akcea Therapeutics Inc shares open at $8.13 in debut vs IPO price of $8/share

http://www.reuters.com/article/brief-akcea-therapeutics-inc-shares-open-idUSFWN1K50CZ




👍️0
Thoro Thoro 7 years ago
AKCA

#MARKET NEWS
JULY 13, 2017 / 8:30 PM / 4 DAYS AGO

BRIEF-Akcea Therapeutics says public offering of 15.6 mln common shares priced at $8 per share

http://www.reuters.com/article/brief-akcea-therapeutics-says-public-off-idUSASA09X2O

👍️0

Your Recent History

Delayed Upgrade Clock